• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏淀粉样变性的病因是否决定了[18F]-氟化钠正电子发射断层显像/计算机断层扫描(PET/CT)的心肌摄取?

Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?

作者信息

Gagliardi Christian, Tabacchi Elena, Bonfiglioli Rachele, Diodato Stefania, Nanni Cristina, Guidalotti Pierluigi, Lorenzini Massimiliano, Lodi Filippo, Milandri Agnese, Rapezzi Claudio, Fanti Stefano

机构信息

Cardio-Thoraco-Vascular Department, DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Nuclear Medicine Unit, DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

出版信息

J Nucl Cardiol. 2017 Apr;24(2):746-749. doi: 10.1007/s12350-016-0457-8. Epub 2016 Mar 14.

DOI:10.1007/s12350-016-0457-8
PMID:26976144
Abstract

Cardiac amyloidosis (CA) leads to variable degrees of myocardial infiltration with a final echocardiographic phenotype of "hypertrophy." Although many non-invasive imaging techniques (MRI, CT, scintigraphy, PET) are useful, the definitive diagnosis is still based on myocardial histology. We explored the possible role of [18F]-NaF PET/CT in the diagnosis of this disease in two cases with wild-type (ATTRwt) or mutant (ATTRm) Ile68Leu transthyretin (TTR)-related CA.

摘要

心脏淀粉样变性(CA)会导致不同程度的心肌浸润,最终的超声心动图表现为“肥厚”。尽管许多非侵入性成像技术(MRI、CT、闪烁扫描、PET)都很有用,但确诊仍基于心肌组织学。我们探讨了[18F]-氟化钠PET/CT在两例野生型(ATTRwt)或突变型(ATTRm)Ile68Leu转甲状腺素蛋白(TTR)相关CA患者中对该病诊断的可能作用。

相似文献

1
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?心脏淀粉样变性的病因是否决定了[18F]-氟化钠正电子发射断层显像/计算机断层扫描(PET/CT)的心肌摄取?
J Nucl Cardiol. 2017 Apr;24(2):746-749. doi: 10.1007/s12350-016-0457-8. Epub 2016 Mar 14.
2
[18F]-NaF PET/CT imaging in cardiac amyloidosis.[18F]-氟化钠正电子发射断层显像/计算机断层扫描成像在心脏淀粉样变中的应用
J Nucl Cardiol. 2016 Aug;23(4):846-9. doi: 10.1007/s12350-015-0287-0. Epub 2015 Sep 24.
3
Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis.检测 18F-NaF PET 对心脏淀粉样变性成像的敏感性。
J Nucl Cardiol. 2021 Feb;28(1):209-218. doi: 10.1007/s12350-019-01675-2. Epub 2019 Mar 4.
4
F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosis.氟[18F]去铁胺 PET/MRI 心肌显像在疑似心脏淀粉样变性患者中的应用。
J Nucl Cardiol. 2021 Aug;28(4):1586-1595. doi: 10.1007/s12350-019-01885-8. Epub 2019 Sep 11.
5
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.淀粉样变性心肌病中心肌 99mTc-DPD 摄取与淀粉样变性病因相关。
Clin Nucl Med. 2015 May;40(5):446-7. doi: 10.1097/RLU.0000000000000741.
6
Feasibility of PiB positron emission tomography/computed tomography for treatment monitoring with Tafamidis in a patient with transthyretin cardiac amyloidosis.用 Tafamidis 进行治疗监测时 PiB 正电子发射断层扫描/计算机断层扫描在转甲状腺素蛋白心脏淀粉样变性患者中的可行性。
J Nucl Cardiol. 2024 Mar;33:101816. doi: 10.1016/j.nuclcard.2024.101816. Epub 2024 Jan 20.
7
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.转甲状腺素相关与轻链心脏淀粉样变性的左心室结构和功能。
Circulation. 2014 May 6;129(18):1840-9. doi: 10.1161/CIRCULATIONAHA.113.006242. Epub 2014 Feb 21.
8
Non-invasive detection and differentiation of cardiac amyloidosis using Tc-pyrophosphate scintigraphy and C-Pittsburgh compound B PET imaging.使用 Tc-焦磷酸盐闪烁扫描和 C-Pittsburgh 化合物 B PET 成像进行非侵入性心脏淀粉样变性的检测和鉴别。
Amyloid. 2020 Dec;27(4):266-274. doi: 10.1080/13506129.2020.1798223. Epub 2020 Jul 28.
9
Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.18F-氟脱氧葡萄糖 PET 心肌淀粉样变显像:一项初步研究。
J Nucl Med. 2016 Nov;57(11):1733-1739. doi: 10.2967/jnumed.115.169870. Epub 2016 Jun 15.
10
Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.ATTR 心脏淀粉样变性患者 18F-NaF 和 99mTc-HDP 骨扫描结果不一致。
Clin Nucl Med. 2018 Mar;43(3):e89-e92. doi: 10.1097/RLU.0000000000001933.

引用本文的文献

1
CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment.CRISPR/Cas9基因编辑:转甲状腺素蛋白淀粉样变性病治疗的新希望。
Ann Med Surg (Lond). 2022 Sep 28;83:104784. doi: 10.1016/j.amsu.2022.104784. eCollection 2022 Nov.
2
Performance of bone tracer for diagnosis and differentiation of transthyretin cardiac amyloidosis: a systematic review and meta-analysis.用于诊断和鉴别转甲状腺素蛋白心脏淀粉样变性的骨示踪剂的性能:系统评价和荟萃分析。
Diagn Interv Radiol. 2021 Nov;27(6):802-810. doi: 10.5152/dir.2021.20662.
3
Cardiac hybrid imaging: novel tracers for novel targets.

本文引用的文献

1
[18F]-NaF PET/CT imaging in cardiac amyloidosis.[18F]-氟化钠正电子发射断层显像/计算机断层扫描成像在心脏淀粉样变中的应用
J Nucl Cardiol. 2016 Aug;23(4):846-9. doi: 10.1007/s12350-015-0287-0. Epub 2015 Sep 24.
2
Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.99mTc-3,3-二膦基-1,2-丙二羧酸闪烁显像在淀粉样变性心肌病病因诊断中的作用及局限性。
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):470-8. doi: 10.1007/s00259-010-1642-7. Epub 2010 Nov 11.
3
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.
心脏混合成像:针对新靶点的新型示踪剂。
J Geriatr Cardiol. 2021 Sep 28;18(9):748-758. doi: 10.11909/j.issn.1671-5411.2021.09.006.
4
Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.心脏淀粉样变评估与管理中的多模态成像
Semin Nucl Med. 2020 Jul;50(4):295-310. doi: 10.1053/j.semnuclmed.2020.01.001. Epub 2020 Feb 9.
5
Update of the Brazilian Guideline on Nuclear Cardiology - 2020.《巴西核心脏病学指南(2020年版)》更新
Arq Bras Cardiol. 2020 Feb;114(2):325-429. doi: 10.36660/abc.20200087.
6
Multi-modality imaging in transthyretin amyloid cardiomyopathy.转甲状腺素蛋白淀粉样变心肌病的多模态成像
World J Cardiol. 2019 Nov 26;11(11):266-276. doi: 10.4330/wjc.v11.i11.266.
7
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.专家共识建议:疑似转甲状腺素蛋白心脏淀粉样变性的诊断。
Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.
8
Molecular Imaging of Cardiac Amyloidosis.心肌淀粉样变性的分子影像学。
Curr Cardiol Rep. 2019 Feb 28;21(3):12. doi: 10.1007/s11886-019-1097-9.
9
Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.老年人群中的转甲状腺素蛋白型心脏淀粉样变:根据相应的诊断和管理目标优化心脏成像
Curr Cardiovasc Risk Rep. 2017 Jun;11. doi: 10.1007/s12170-017-0541-x. Epub 2017 Apr 25.
10
Use of fluorine-18 sodium fluoride for the diagnosis of transthyretin cardiac amyloidosis: The birth of a new technique.使用氟-18 氟化钠诊断转甲状腺素蛋白心脏淀粉样变性:一项新技术的诞生。
J Nucl Cardiol. 2018 Oct;25(5):1568-1570. doi: 10.1007/s12350-017-0847-6. Epub 2017 Mar 29.
系统性心脏淀粉样变:3种主要类型的疾病特征与临床病程
Circulation. 2009 Sep 29;120(13):1203-12. doi: 10.1161/CIRCULATIONAHA.108.843334. Epub 2009 Sep 14.